Health Minister Aaron Motsoaledi addresses concerns over the limited rollout of Lenacapavir, a groundbreaking HIV prevention ...
The Gauteng health department has exceeded its first-month target for rolling out Lenacapavir, a long-acting HIV prevention ...
Lenacapavir is a gamechanger in the field of global health, signifying a shift from HIV prevention that requires a daily ...
The department said a total of 1,140 people have started using Lenacapavir, which was launched with 29,000 doses in high-risk areas.
Share on Pinterest A drug used to treat HIV infections can also effectively prevent them, a new clinical trial demonstrates. Image credit: luza studios/Getty Images. Human immunodeficiency virus (HIV) ...
allAfrica.com on MSN
'One Injection Protects Up to Six Months' - What Is New HIV Drug Lenacapavir?
As South Africa becomes the ninth African country to introduce the use of new long-acting drug lenacapavir for HIV prevention, RFI spoke with infectious disease specialist Ndong Essomba Bitchoka about ...
Malawi breaking news publishing 24 hours a day news about Malawi, Malawi Business, Malawi Tourism, Malawi Politics, Malawi News ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV ...
Gauteng has surpassed its first-month target for the rollout of Lenacapavir, with eligible clients receiving the long-acting ...
eNCA on MSN
Gauteng exceeds lenacapavir rollout target
The Health Department says the strong uptake of Lenacapavir is an encouraging sign that communities are embracing the ...
In a historic moment in the fight against the HIV/Aids pandemic, preventative medication is now available. The struggle is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results